Janux Therapeutics, Inc.
JANX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $431 | $19 | $51 | $36 |
| Short-Term Investments | $595 | $325 | $276 | $339 |
| Receivables | $5 | $0 | $1 | $0 |
| Inventory | $0 | $0 | -$1 | $0 |
| Other Curr. Assets | $3 | $5 | $5 | $2 |
| Total Curr. Assets | $1,034 | $349 | $332 | $377 |
| Property Plant & Equip (Net) | $24 | $28 | $29 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $3 | $1 | $1 |
| Total NC Assets | $28 | $31 | $32 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,062 | $380 | $364 | $380 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $2 | $2 |
| Short-Term Debt | $2 | $2 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $5 | $5 |
| Other Curr. Liab. | $12 | $7 | $8 | $5 |
| Total Curr. Liab. | $17 | $13 | $17 | $13 |
| LT Debt | $21 | $23 | $25 | $0 |
| Deferred Rev, NC | $0 | $0 | $2 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $21 | $23 | $27 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $23 | $25 | $25 | $0 |
| Total Liabilities | $39 | $36 | $43 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$238 | -$169 | -$110 | -$47 |
| AOCI | $2 | $1 | -$2 | -$0 |
| Other Equity | $1,258 | $512 | $433 | $414 |
| Total Equity | $1,023 | $344 | $321 | $366 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,062 | $380 | $364 | $380 |
| Net Debt | -$408 | $5 | -$26 | -$35 |